Position history for Champlain Investment Partners, LLC's holdings in REPLIGEN CORP
Champlain Investment Partners, LLC holds 693,855 shares of RGEN (REPLIGEN CORP), worth $81.7M as of 2026-Q1. The position was decreased (-30.9% shares). RGEN represents 1.0% of Champlain Investment Partners, LLC's portfolio.
Current Value
$81.7M
Current Shares
693,855
Total Value Change
+$9.8M
Total Shares Change
+123,265
Other major holders of RGEN: Select Equity Group, L.P.
Decreased |
| 693,855 |
-30.9% |
| $81.7M |
| 1.0% |
| $123.06 |
0 |
| 2025-Q4 | Decreased | 1M | -25.0% | $164.5M | 1.7% | $166.59 | 0 |
| 2025-Q3 | Decreased | 1.3M | -4.4% | $179M | 1.3% | $124.09 | 0 |
| 2025-Q2 | Decreased | 1.4M | -4.3% | $174.3M | 1.2% | $123.56 | 0 |
| 2025-Q1 | Decreased | 1.5M | -5.2% | $186.3M | 1.3% | $133.41 | 0 |
| 2024-Q4 | Increased | 1.5M | +8.6% | $222.2M | 1.4% | $143.81 | 53 |
| 2024-Q3 | Increased | 1.4M | +149.0% | $211.5M | 1.3% | $145.93 | 78 |
| 2024-Q2 | Decreased | 570,590 | -0.8% | $71.9M | 0.4% | $126.06 | 0 |